JP Morgan Chase
VNDA icon

JP Morgan Chase’s Vanda Pharmaceuticals VNDA Stock Holding History

JP Morgan Chase’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-85,400
Closed -$2.23M – 6075
2018
Q4 		$2.23M Buy
+85,400
New +$2.01M ﹤0.01% 3204

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase's VNDA Position: Q2 2026 in Review

JP Morgan Chase reduced its Vanda Pharmaceuticals (VNDA) stake by 4% in Q2 2026, selling an estimated $79.5K and leaving 292,724 shares worth $1.8M. The position accounts for ﹤0.01% of the portfolio, ranked #4262.

JP Morgan Chase first reported a position in VNDA in Q4 2015 and has held it in 43 quarters since. The position peaked at $8.04M in Q2 2021. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • JP Morgan Chase held 292,724 shares of Vanda Pharmaceuticals worth $1.8M as of Q2 2026.
  • JP Morgan Chase sold 12,170 Vanda Pharmaceuticals shares in Q2 2026, an estimated $79.5K.
  • Vanda Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4262 holding.
  • JP Morgan Chase first reported a position in Vanda Pharmaceuticals in Q4 2015 and has held it in 43 quarters since.
  • JP Morgan Chase's Vanda Pharmaceuticals position peaked at $8.04M in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.